Rasburicase improves the outcome of acute kidney injury from typical hemolytic uremic syndrome
ConclusionsChildren with typical HUS treated with rasburicase had shorter hospital stays and less long-term sequelae at 1-year post-discharge than those who were not treated with rasburicase. These results support the use of rasburicase to prevent CKD in pediatric patients with typical HUS-associated AKI.Graphical Abstract
Source: Pediatric Nephrology - Category: Urology & Nephrology Source Type: research
More News: Children | Chronic Kidney Disease | Dialysis | Hemolytic Uremic Syndrome (HUS) | Hypertension | Pediatrics | Proteinuria | Urology & Nephrology